On the recordOctober 26, 2023
Patients deserve a promising pathway at the FDA.
Source
congress.govPatients deserve a promising pathway at the FDA.
Emphasizing the need for better drug approval for rare diseases.
Share
More from Mike Braun
It gives us the option on difficult places — like infrastructure, reining in healthcare costs, early childhood learning — to invest, give some relief to taxpayers.
The whole assessment system is something that needs to be looked at.
Government has to intervene, because healthcare is run like an unregulated utility.